Oramed Pharmaceuticals Inc (ORMP)
2.30
-0.03
(-1.29%)
USD |
NASDAQ |
May 17, 16:00
2.305
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Asset Impairment Charge (Quarterly)
Asset Impairment Charge (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Asset Impairment Charge (Quarterly) Data
Date | Value |
---|---|
November 30, 2012 | -- |
August 31, 2012 | -- |
May 31, 2012 | -- |
February 29, 2012 | -- |
November 30, 2011 | -- |
August 31, 2011 | -- |
May 31, 2011 | -- |
February 28, 2011 | -- |
November 30, 2010 | -- |
August 31, 2010 | -- |
Date | Value |
---|---|
May 31, 2010 | -- |
February 28, 2010 | -- |
November 30, 2009 | -- |
August 31, 2009 | -- |
May 31, 2009 | -- |
February 28, 2009 | -- |
November 30, 2008 | -- |
August 31, 2008 | -- |
May 31, 2008 | -- |
February 29, 2008 | -- |
Asset Impairment Charge Definition
Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.
Asset Impairment Charge (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median